---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-018156"
form_type: "8-K"
ticker: "ZVSA"
cik: "0001859007"
company_name: "ZyVersa Therapeutics, Inc."
filed_at: "2025-10-15T23:59:59+00:00"
generated_at: "2026-05-17T03:47:06.798403+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ZyVersa CMO Pablo Guzman resigns Oct 10, 2025 to focus on family

## Summary
- Pablo Guzman, M.D., resigned as CMO and SVP of Medical Affairs, effective October 10, 2025.
- Dr. Guzman joined ZyVersa in January 2015 with over 35 years of medical experience.
- Resignation reason: personal (spend time with family and travel); no replacement announced.

## SEC filing metadata
- accession: 0001493152-25-018156
- form_type: 8-K
- ticker: ZVSA
- cik: 0001859007
- company_name: ZyVersa Therapeutics, Inc.
- filed_at: 2025-10-15T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859007/000149315225018156/0001493152-25-018156-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859007/000149315225018156/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-018156
- JSON: https://secwatch.observer/filing/0001493152-25-018156.json
- Plain text: https://secwatch.observer/filing/0001493152-25-018156.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.